Unknown

Dataset Information

0

Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy.


ABSTRACT: New strategies to fabricate nanomedicines with high translational capacity are urgently desired. Herein, a new class of self-assembled drug cocktails that addresses the multiple challenges of manufacturing clinically useful cancer nanomedicines was reported. Methods: With the aid of a molecular targeted agent, dasatinib (DAS), cytotoxic cabazitaxel (CTX) forms nanoassemblies (CD NAs) through one-pot process, with nearly quantitative entrapment efficiency and ultrahigh drug loading of up to 100%. Results: Surprisingly, self-assembled CD NAs show aggregation-induced emission, enabling particle trafficking and drug release in living cells. In preclinical models of human cancer, including a patient-derived melanoma xenograft, CD NAs demonstrated striking therapeutic synergy to produce a durable recession in tumor growth. Impressively, CD NAs alleviated the toxicity of the parent CTX agent and showed negligible immunotoxicity in animals. Conclusions: Overall, this approach does not require any carrier matrices, offering a scalable and cost-effective methodology to create a new generation of nanomedicines for the safe and efficient delivery of drug combinations.

SUBMITTER: Chen X 

PROVIDER: S-EPMC8058735 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5930166 | biostudies-literature
| S-EPMC3119512 | biostudies-other
| S-EPMC3926814 | biostudies-literature
| S-EPMC10560439 | biostudies-literature
| S-EPMC6045401 | biostudies-literature
| S-EPMC5778127 | biostudies-literature
| S-EPMC5716876 | biostudies-literature
| S-EPMC6964014 | biostudies-literature
| S-EPMC3983132 | biostudies-other
| S-EPMC4195523 | biostudies-literature